Analysts See $0.01 EPS for EDAP TMS S.A. (EDAP)

March 7, 2018 - By Adrian Erickson

 Analysts See $0.01 EPS for EDAP TMS S.A. (EDAP)

Analysts expect EDAP TMS S.A. (NASDAQ:EDAP) to report $0.01 EPS on April, 2.They anticipate $0.04 EPS change or 133.33 % from last quarter’s $-0.03 EPS. EDAP’s profit would be $289,978 giving it 56.25 P/E if the $0.01 EPS is correct. After having $-0.02 EPS previously, EDAP TMS S.A.’s analysts see -150.00 % EPS growth. The stock decreased 0.88% or $0.02 during the last trading session, reaching $2.25. About 156,168 shares traded or 154.76% up from the average. EDAP TMS S.A. (NASDAQ:EDAP) has declined 15.92% since March 8, 2017 and is downtrending. It has underperformed by 32.62% the S&P500.

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company has market cap of $65.25 million. The firm operates in two divisions: High Intensity Focused Ultrasound , and Urology Devices and Services (UDS). It currently has negative earnings. The HIFU division develops, makes, and markets devices for the minimally invasive destruction of various types of localized tumors using HIFU technology.

Another recent and important EDAP TMS S.A. (NASDAQ:EDAP) news was published by which published an article titled: “EDAP TMS SA ADR EDAP (US: Nasdaq)” on February 11, 2011.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: